A tetravalent alphavirus-vector based Dengue vaccine provides effective immunity in an early life mouse model

Dengue viruses (DENV1-4) cause 390 million clinical infections every year, several hundred thousand of which progress to severe hemorrhagic and shock syndromes. Preexisting immunity resulting from a previous DENV infection is the major risk factor for severe dengue during secondary heterologous infe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Vaccine
Main Authors: Khalil, Syed Muaz, Tonkin, Daniel R., Mattocks, Melissa D., Snead, Andrew T., Johnston, Robert E., White, Laura J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4487803/
https://ncbi.nlm.nih.gov/pubmed/24882043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2014.05.053
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados